We are live on
!
Find out more
EMG
ETF Managers Group Portfolio holdings
AUM
$3.1B
Turnover
42.86%
1-Year Est. Return
17.12%
This Fund
S&P 500
This Quarter
Est. Return
+5.57%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
–
AUM
$6.13B
AUM Growth
+$505M
(+9%)
Cap. Flow
+$205M
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
831
New
162
Increased
239
Reduced
241
Closed
184
Avg Time Held
1.7
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VALT
ETFMG Sit Ultra Short ETF
VALT
|
+$79.6M |
| 2 |
Tilray
TLRY
|
+$56.8M |
| 3 |
Aurora Cannabis
ACB
|
+$54.4M |
| 4 |
Canopy Growth
CGC
|
+$51.6M |
| 5 |
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$187M |
| 2 |
APHA
Aphria Inc. Common Shares
APHA
|
+$182M |
| 3 |
Hecla Mining
HL
|
+$43.6M |
| 4 |
Mativ Holdings
MATV
|
+$21.5M |
| 5 |
BlackBerry
BB
|
+$21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.87% |
| 2 | Healthcare | 15.14% |
| 3 | Materials | 14.7% |
| 4 | Financials | 7.38% |
| 5 | Consumer Staples | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CLDR
551
DELISTED
Cloudera, Inc.
CLDR
| $442K | 0.01% |
28,020
-78,542
| -74% | -$1.07M |
2020 Q1
5 quarters
|
|
|
MSP
552
DELISTED
Datto Holding Corp.
MSP
| $433K | 0.01% |
15,425
-1,329
| -8% | -$34.1K |
2020 Q4
2 quarters
|
|
553
PowerFleet Inc
AIOT
$334M
| $424K | 0.01% |
56,401
-40,449
| -42% | -$295K |
2019 Q4
6 quarters
|
|
554
DELISTED
Esperion Therapeutics
ESPR
| $423K | 0.01% |
19,996
+6,417
| +47% | +$155K |
2021 Q1
1 quarter
|
|
555
Kamada
KMDA
$452M
| $420K | 0.01% |
71,186
-37,902
| -35% | -$227K |
2018 Q4
10 quarters
|
|
|
NEWR
556
DELISTED
New Relic, Inc.
NEWR
| $420K | 0.01% |
6,102
-464
| -7% | -$29.9K |
2018 Q4
10 quarters
|
|
557
Redhill Biopharma
RDHL
$4.44M
| $419K | 0.01% |
60
-19
| -24% | -$131K |
2018 Q3
11 quarters
|
|
558
DELISTED
Warner Bros
WBD
| $418K | 0.01% |
13,784
-2,735
| -17% | -$94.9K |
2020 Q2
4 quarters
|
|
559
Eli Lilly
LLY
$1.12T
| $408K | 0.01% |
1,778
-2,341
| -57% | -$470K |
2020 Q2
4 quarters
|
|
560
DELISTED
Hologic
HOLX
| $407K | 0.01% |
5,915
+770
| +15% | +$51.5K |
2020 Q4
2 quarters
|
|
561
QuantumScape Corp
QS
$2.62B
| $407K | 0.01% |
+13,425
| New | +$434K |
2021 Q2
0 quarters
|
|
562
Box
BOX
$5.42B
| $392K | 0.01% |
15,290
-1,224
| -7% | -$28.5K |
2020 Q1
5 quarters
|
|
563
Rackspace Technology
RXT
$813M
| $392K | 0.01% |
19,867
-1,577
| -7% | -$34.9K |
2020 Q3
3 quarters
|
|
564
Regeneron Pharmaceuticals
REGN
$82B
| $389K | 0.01% |
712
-94
| -12% | -$47.6K |
2020 Q2
4 quarters
|
|
565
Abbott
ABT
$181B
| $387K | 0.01% |
3,302
+181
| +6% | +$21.1K |
2020 Q1
5 quarters
|
|
566
DELISTED
Jamf
JAMF
| $386K | 0.01% |
11,260
-905
| -7% | -$30.8K |
2020 Q3
3 quarters
|
|
567
AstraZeneca
AZN
$259B
| $385K | 0.01% |
3,200
-636
| -17% | -$69.8K |
2020 Q2
4 quarters
|
|
568
FuelCell Energy
FCEL
$1.13B
| $379K | 0.01% |
+1,390
| New | +$406K |
2021 Q2
0 quarters
|
|
|
ALXN
569
DELISTED
Alexion Pharmaceuticals
ALXN
| $377K | 0.01% |
2,048
-389
| -16% | -$66.8K |
2020 Q3
3 quarters
|
|
570
GSK
GSK
$98.2B
| $372K | 0.01% |
7,442
-1,013
| -12% | -$48.7K |
2020 Q2
4 quarters
|
|
571
Gilead Sciences
GILD
$195B
| $368K | 0.01% |
5,420
-307
| -5% | -$20.5K |
2020 Q1
5 quarters
|
|
572
UroGen Pharma
URGN
$1.79B
| $367K | 0.01% |
23,044
-16,648
| -42% | -$301K |
2018 Q3
11 quarters
|
|
|
NSTG
573
DELISTED
NanoString Technologies, Inc.
NSTG
| $367K | 0.01% |
+5,379
| New | +$341K |
2021 Q2
0 quarters
|
|
574
Sanofi
SNY
$96.5B
| $366K | 0.01% |
6,936
-958
| -12% | -$50K |
2020 Q2
4 quarters
|
|
575
Takeda Pharmaceutical
TAK
$62.1B
| $365K | 0.01% |
21,703
+930
| +4% | +$15.8K |
2020 Q2
4 quarters
|
|
Similar funds
PFM
HT
JCG
QA
BFG
IMOV
ETF Managers Group's Q2 2021 Portfolio in Review
As of Q2 2021, ETF Managers Group held 831 positions worth $6.13B, up 9% from $5.63B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ETF Managers Group deployed $205M of net new capital in Q2 2021, opening 162 new positions and adding to 239 existing holdings. Its largest new stake was KnowBe4, Inc. Class A Common Stock: 2,250,843 shares worth $74.9M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 42% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Hecla Mining, an estimated $43.6M trimmed.
- ETF Managers Group's largest Q2 2021 buy was KnowBe4, Inc. Class A Common Stock: 2,250,843 shares worth $74.9M.
- ETF Managers Group added most to ETFMG Sit Ultra Short ETF in Q2 2021, an estimated $79.6M increase.
- ETF Managers Group's biggest Q2 2021 reduction was Hecla Mining, cutting an estimated $43.6M.
- ETF Managers Group fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $187M.
- ETF Managers Group's ten largest holdings make up 20% of its $6.13B portfolio in Q2 2021.
- ETF Managers Group opened 162 new positions and closed 184 in Q2 2021.
- ETF Managers Group's portfolio value rose 9% quarter-over-quarter to $6.13B.
Based on ETF Managers Group's 13F filing for Q2 2021, filed 16 Aug 2021.